| Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for … JJ Morigi, PD Stricker, PJ van Leeuwen, R Tang, B Ho, Q Nguyen, ... Journal of nuclear medicine 56 (8), 1185-1190, 2015 | 632 | 2015 |
| Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen … R Choo, L Klotz, C Danjoux, GC Morton, G DeBoer, E Szumacher, ... The Journal of urology 167 (4), 1664-1669, 2002 | 417 | 2002 |
| The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study PJ Roach, R Francis, L Emmett, E Hsiao, A Kneebone, G Hruby, T Eade, ... Journal of Nuclear Medicine 59 (1), 82-88, 2018 | 369 | 2018 |
| How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally III cancer patients? A systematic review E Chow, T Harth, G Hruby, J Finkelstein, J Wu, C Danjoux Clinical Oncology 13 (3), 209-218, 2001 | 339 | 2001 |
| UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas SQ Wong, K Waldeck, IA Vergara, J Schröder, J Madore, JS Wilmott, ... Cancer research 75 (24), 5228-5234, 2015 | 332 | 2015 |
| 68Ga‐PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment PJ van Leeuwen, P Stricker, G Hruby, A Kneebone, F Ting, B Thompson, ... BJU international 117 (5), 732-739, 2016 | 311 | 2016 |
| Treatment outcomes from 68Ga-PSMA PET/CT–informed salvage radiation treatment in men with rising PSA after radical prostatectomy: prognostic value of a negative PSMA PET L Emmett, PJ van Leeuwen, R Nandurkar, MJ Scheltema, T Cusick, ... Journal of Nuclear Medicine 58 (12), 1972-1976, 2017 | 183 | 2017 |
| Rapid modulation of PSMA expression by androgen deprivation: serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen … L Emmett, C Yin, M Crumbaker, G Hruby, A Kneebone, R Epstein, ... Journal of Nuclear Medicine 60 (7), 950-954, 2019 | 173 | 2019 |
| Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases JY Chen, G Hruby, RA Scolyer, R Murali, A Hong, P FitzGerald, TT Pham, ... Cancer 113 (10), 2770-2778, 2008 | 151 | 2008 |
| Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease—results from a … J Jabbour, R Cumming, RA Scolyer, G Hruby, JF Thompson, S Lee Annals of Surgical Oncology 14, 1943-1952, 2007 | 133 | 2007 |
| PSA doubling time of prostate carcinoma managed with watchful observation alone R Choo, G DeBoer, L Klotz, C Danjoux, GC Morton, E Rakovitch, ... International Journal of Radiation Oncology* Biology* Physics 50 (3), 615-620, 2001 | 125 | 2001 |
| Stereotactic body radiotherapy for oligometastatic prostate cancer detected via prostate-specific membrane antigen positron emission tomography A Kneebone, G Hruby, H Ainsworth, K Byrne, C Brown, L Guo, A Guminski, ... European Urology Oncology 1 (6), 531-537, 2018 | 119 | 2018 |
| The role of FDG-PET in the initial staging and response assessment of anal cancer: a systematic review and meta-analysis M Jones, G Hruby, M Solomon, N Rutherford, J Martin Annals of surgical oncology 22, 3574-3581, 2015 | 115 | 2015 |
| Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer JD Harrison, MJ Solomon, JM Young, A Meagher, P Butow, G Salkeld, ... Archives of Surgery 143 (4), 389-394, 2008 | 110 | 2008 |
| Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy RE Warner, MJ Quinn, G Hruby, RA Scolyer, RF Uren, JF Thompson Annals of Surgical Oncology 15, 2509-2518, 2008 | 107 | 2008 |
| Adjuvant whole-brain radiation therapy compared with observation after local treatment of melanoma brain metastases: a multicenter, randomized phase III trial AM Hong, GB Fogarty, K Dolven-Jacobsen, BH Burmeister, SN Lo, ... Journal of clinical oncology 37 (33), 3132-3141, 2019 | 105 | 2019 |
| Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence P Butow, S Kelly, B Thewes, G Hruby, L Sharpe, J Beith Psycho‐oncology 24 (4), 416-423, 2015 | 105 | 2015 |
| 3-Year freedom from progression after 68Ga-PSMA PET/CT–triaged management in men with biochemical recurrence after radical prostatectomy: results of a prospective multicenter trial L Emmett, R Tang, R Nandurkar, G Hruby, P Roach, JA Watts, T Cusick, ... Journal of Nuclear Medicine 61 (6), 866-872, 2020 | 104 | 2020 |
| Patients with advanced cancer: a survey of the understanding of their illness and expectations from palliative radiotherapy for symptomatic metastases E Chow, L Andersson, R Wong, M Vachon, G Hruby, E Franssen, ... Clinical Oncology 13 (3), 204-208, 2001 | 103 | 2001 |
| Diagnostic accuracy of 68Ga‐prostate‐specific membrane antigen (PSMA) positron‐emission tomography (PET) and multiparametric (mp)MRI to detect intermediate‐grade … MJ Scheltema, JI Chang, PD Stricker, PJ van Leeuwen, QA Nguyen, B Ho, ... BJU international 124, 42-49, 2019 | 100 | 2019 |
